Goldman Sachs Group Inc Regeneron Pharmaceuticals, Inc. Call Options Transaction History

Goldman Sachs Group Inc

$605 Billion
Q3 2024

Call Options

19 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$1024.09 - $1201.76 $31.6 Million - $37.1 Million	30,900 Added 12.0%	288,400 $303 Million
Q2 2024 Aug 13, 2024	BUY	$883.2 - $1071.19 $191 Million - $232 Million	216,500 Added 528.05%	257,500 $271 Million
Q1 2024 May 15, 2024	SELL	$902.69 - $993.35 $1.72 Million - $1.89 Million	-1,900 Reduced 4.43%	41,000 $39.5 Million
Q4 2023 Feb 13, 2024	BUY	$775.18 - $881.7 $14.1 Million - $16 Million	18,200 Added 73.68%	42,900 $37.7 Million
Q3 2023 May 14, 2024	SELL	$692.45 - $844.37 $12.6 Million - $15.4 Million	-18,200 Reduced 42.42%	24,700 $20.3 Million
Q3 2023 Nov 14, 2023	SELL	$692.45 - $844.37 $11.8 Million - $14.4 Million	-17,000 Reduced 40.77%	24,700 $20.3 Million
Q2 2023 May 14, 2024	SELL	$700.03 - $830.35 $11.9 Million - $14.1 Million	-17,000 Reduced 28.96%	41,700 $30 Million
Q2 2023 Aug 14, 2023	SELL	$700.03 - $830.35 $11.9 Million - $14.1 Million	-17,000 Reduced 28.96%	41,700 $30 Million
Q1 2023 May 14, 2024	SELL	$680.49 - $826.97 $28.6 Million - $34.8 Million	-42,100 Reduced 41.77%	58,700 $48.2 Million
Q1 2023 May 11, 2023	SELL	$680.49 - $826.97 $28.6 Million - $34.8 Million	-42,100 Reduced 41.77%	58,700 $48.2 Million
Q4 2022 May 14, 2024	BUY	$705.89 - $766.39 $63.4 Million - $68.8 Million	89,800 Added 816.36%	100,800 $72.7 Million
Q4 2022 Feb 13, 2023	BUY	$705.89 - $766.39 $63.4 Million - $68.8 Million	89,800 Added 816.36%	100,800 $72.7 Million
Q3 2022 May 14, 2024	BUY	$573.97 - $724.32 $2.41 Million - $3.04 Million	4,200 Added 61.76%	11,000 $7.58 Million
Q3 2022 Nov 10, 2022	BUY	$573.97 - $724.32 $2.41 Million - $3.04 Million	4,200 Added 61.76%	11,000 $7.58 Million
Q2 2022 May 14, 2024	SELL	$548.35 - $738.84 $19.8 Million - $26.7 Million	-36,100 Reduced 84.15%	6,800 $4.02 Million
Q2 2022 Aug 15, 2022	SELL	$548.35 - $738.84 $6.53 Million - $8.79 Million	-11,900 Reduced 63.64%	6,800 $4.02 Million
Q1 2022 May 16, 2022	BUY	$595.12 - $698.43 $7.38 Million - $8.66 Million	12,400 Added 196.83%	18,700 $13.1 Million
Q4 2021 Feb 14, 2022	BUY	$543.48 - $670.97 $1.41 Million - $1.74 Million	2,600 Added 70.27%	6,300 $3.98 Million
Q3 2021 Nov 10, 2021	BUY	$574.03 - $680.96 $2.12 Million - $2.52 Million	3,700 New	3,700 $2.24 Million

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.6M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.2B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Account